| Literature DB >> 19473992 |
Xiaoming Yang1, Hongchang Li, Zinan Zhou, Wen-Horng Wang, Anping Deng, Ourania Andrisani, Xiaoqi Liu.
Abstract
Polo-like kinase 1 (Plk1) overexpression is associated with tumorigenesis by an unknown mechanism. Likewise, Plk1 was suggested to act as a negative regulator of tumor suppressor p53, but the mechanism remains to be determined. Herein, we have identified topoisomerase I-binding protein (Topors), a p53-binding protein, as a Plk1 target. We show that Plk1 phosphorylates Topors on Ser(718) in vivo. Significantly, expression of a Plk1-unphosphorylatable Topors mutant (S718A) leads to a dramatic accumulation of p53 through inhibition of p53 degradation. Topors is an ubiquitin and small ubiquitin-like modifier ubiquitin-protein isopeptide ligase (SUMO E3) ligase. Plk1-mediated phosphorylation of Topors inhibits Topors-mediated sumoylation of p53, whereas p53 ubiquitination is enhanced, leading to p53 degradation. These results demonstrate that Plk1 modulates Topors activity in suppressing p53 function and identify a likely mechanism for the tumorigenic potential of Plk1.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19473992 PMCID: PMC2707202 DOI: 10.1074/jbc.C109.001560
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157